Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
28,950
-50 (-0.17%)
Apr 24, 2026, 3:30 PM KST
11.35% (1Y)
| Market Cap | 170.52B +14.2% |
| Revenue (ttm) | 208.61B +2.2% |
| Net Income | 27.64B -18.1% |
| EPS | n/a |
| Shares Out | 5.88M |
| PE Ratio | 6.17 |
| Forward PE | 5.18 |
| Dividend | 900.00 (3.10%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 8,064 |
| Average Volume | 10,175 |
| Open | 29,000 |
| Previous Close | 29,000 |
| Day's Range | 28,900 - 29,200 |
| 52-Week Range | 25,800 - 33,950 |
| Beta | 0.22 |
| RSI | 49.09 |
| Earnings Date | May 15, 2026 |